![](https://ml.globenewswire.com/media/9434e9f6-9469-41d9-91da-df1b48d460e2/small/algernon-logo-1-png.png)
Algernon Provides Update on Phase 2 Human Testing of Ifenprodil for COVID-19
VANCOUVER, British Columbia, April 02, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that the …